| OAC0103 | Characterising HIV incidence among people who inject drugs engaged with harm-reduction programs in four provinces in South Africa | Oral abstract session with live Q&A | Epidemiology of HIV |
| OAC0102 | Australia’s progress towards ending HIV as a public health threat: trends in epidemiological metrics over 2004-2021 | Oral abstract session with live Q&A | Surveillance: Measuring the HIV epidemic |
| OAB0405 | Re-evaluating risk: evaluating opioid-related harm associated with stimulant use in people with chronic pain living with and without HIV | Oral abstract session with live Q&A | Co-morbidities |
| OAB0405 | Re-evaluating risk: evaluating opioid-related harm associated with stimulant use in people with chronic pain living with and without HIV | Oral abstract session with live Q&A | Co-morbidities |
| OAB0404 | Effects of lifestyle modification and annual screening in the prevention of cardiovascular risk factors in South African women with HIV | Oral abstract session with live Q&A | Co-morbidities |
| OAB0403 | Vitamin D and calcium intake are associated with bone deficits among adolescents living with HIV in Zambia and Zimbabwe | Oral abstract session with live Q&A | Co-morbidities |
| OAB0402 | Integrase strand inhibitors (INSTI) related changes in BMI and risk of diabetes | Oral abstract session with live Q&A | Co-morbidities |
| OAB0305 | Co-infection of High-Risk Human Papillomavirus and Human T-Lymphotropic Virus-1 among women living with HIV on Antiretroviral Therapy at a Tertiary Hospital in Kenya | Oral abstract session with live Q&A | Co-infections (including opportunistic infections) |
| OAB0304 | Short-course rifapentine-based regimens for latent tuberculosis infection among people living with HIV who received integrase inhibitor-based antiretroviral therapy | Oral abstract session with live Q&A | Co-infections (including opportunistic infections) |
| OAB0303 | High rate of hepatitis C and reinfection after direct-acting antiviral treatment among men-who-have-sex-with-men living with HIV in Bangkok, Thailand | Oral abstract session with live Q&A | Co-infections (including opportunistic infections) |